Julian Baker’s Nuvalent NUVL Stock Holding History

Julian Baker’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-143,937	Closed	-$14.5M	–	89
2025 Q4	$14.5M	Hold	143,937	–	–	0.08%	65
2025 Q3	$12.4M	Hold	143,937	–	–	0.09%	61
2025 Q2	$11M	Buy	+143,937	New	+$10.5M	0.11%	53

Other funds holding NUVL

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Julian Baker's NUVL Position: Q1 2026 in Review

Julian Baker sold out of Nuvalent (NUVL) in Q1 2026, closing a stake of 143,937 shares — an estimated $14.5M sold.

Julian Baker first reported a position in NUVL in Q2 2025 and held it in 3 quarters. The position peaked at $14.5M in Q4 2025. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

Julian Baker reported no remaining Nuvalent position as of Q1 2026 after selling out during the quarter.
Julian Baker sold 143,937 Nuvalent shares in Q1 2026, an estimated $14.5M.
Julian Baker first reported a position in Nuvalent in Q2 2025 and held it in 3 quarters.
Julian Baker's Nuvalent position peaked at $14.5M in Q4 2025.
263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Baker Bros. Advisors's 13F filing for Q1 2026, filed 15 May 2026.